While an inverse correlation between CD9 expression and metastatic development was observed in melanoma, cervical carcinoma and multiple myeloma, up-regulation of CD9 was demonstrated in aggressive gastric carcinoma [20] and high-grade astrocytic tumors [21]. This evidence concerns the gene CD9 and astrocytic tumor.